Applying the ESMO-Magnitude of Clinical Benefit Scale in real life

Por Ciardiello, Fortunato, Tabernero, Josep
Publicado no ESMO Open (2016)

Panitumumab: the evidence of its therapeutic potential in metastatic colorectal cancer care

Por Martinelli, Erika, Morgillo, Floriana, Troiani, Teresa, Tortora, Giampaolo, Ciardiello, Fortunato
Publicado em 2007

Mechanisms of resistance to EGFR-targeted drugs: lung cancer

Por Morgillo, Floriana, Della Corte, Carminia Maria, Fasano, Morena, Ciardiello, Fortunato
Publicado no ESMO Open (2016)

Treatment of esophagogastric junction carcinoma: An unsolved debate

Por Orditura, Michele, Galizia, Gennaro, Lieto, Eva, De Vita, Ferdinando, Ciardiello, Fortunato
Publicado no World J Gastroenterol (2015)

ESMO and WHO: 14 years of working in partnership on cancer control

Por Ullrich, Andreas, Ciardiello, Fortunato, Bricalli, Gracemarie, Cherny, Nathan I, Eniu, Alexandru
Publicado no ESMO Open (2016)

Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown?

Por Sgambato, Assunta, Casaluce, Francesca, Maione, Paolo, Rossi, Antonio, Ciardiello, Fortunato, Gridelli, Cesare
Publicado em 2014

Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy

Por Fasano, Morena, Della Corte, Carminia Maria, Papaccio, Federica, Ciardiello, Fortunato, Morgillo, Floriana
Publicado no J Thorac Oncol (2015)

Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer

Por Della Corte, Carminia Maria, Fasano, Morena, Papaccio, Federica, Ciardiello, Fortunato, Morgillo, Floriana
Publicado no Biomedicines (2014)

The Potential Role of Pharmacogenomic and Genomic in the Adjuvant Treatment of Early Stage Non Small Cell Lung Cancer

Por Schettino, Clorinda, Bareschino, Maria A, Maione, Paolo, Rossi, Antonio, Ciardiello, Fortunato, Gridelli, Cesare
Publicado em 2008

Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors

Por Morgillo, Floriana, Martinelli, Erika, Troiani, Teresa, Orditura, Michele, De Vita, Ferdinando, Ciardiello, Fortunato
Publicado em 2011

Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?

Por Troiani, Teresa, Martinelli, Erika, Morgillo, Floriana, Capasso, Anna, Nappi, Anna, Sforza, Vincenzo, Ciardiello, Fortunato
Publicado em 2013

Quality to rely on: meeting report of the 5th Meeting of External Quality Assessment, Naples 2016

Por van Krieken, Han, Deans, Sandi, Hall, Jacqueline A, Normanno, Nicola, Ciardiello, Fortunato, Douillard, Jean-Yves
Publicado no ESMO Open (2016)

Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence

Por Troiani, Teresa, Napolitano, Stefania, Della Corte, Carminia Maria, Martini, Giulia, Martinelli, Erika, Morgillo, Floriana, Ciardiello, Fortunato
Publicado no ESMO Open (2016)

Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A

Por Tortora, Giampaolo, Caputo, Rosa, Damiano, Vincenzo, Bianco, Roberto, Pepe, Stefano, Bianco, A. Raffaele, Jiang, Zhiwei, Agrawal, Sudhir, Ciardiello, Fortunato
Publicado em 1997

Targeting vascular endothelial growth factor receptor-1 and -3 with cediranib (AZD2171): effects on migration and invasion of gastrointestinal cancer cell lines

Por Morelli, M. Pia, Brown, Amy M., Pitts, Todd M., Tentler, John J., Ciardiello, Fortunato, Ryan, Anderson, Jürgensmeier, Juliane M., Eckhardt, S. Gail
Publicado em 2009

Critical appraisal of the use of regorafenib in the management of colorectal cancer

Por Festino, Lucia, Fabozzi, Alessio, Manzo, Anna, Gambardella, Valentina, Martinelli, Erika, Troiani, Teresa, De Vita, Ferdinando, Orditura, Michele, Ciardiello, Fortunato, Morgillo, Floriana
Publicado em 2013

Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass

Por Orditura, Michele, Lieto, Eva, Ferraraccio, Francesca, De Cataldis, Giuseppe, Troiani, Teresa, Castellano, Paolo, Catalano, Giuseppe, Ciardiello, Fortunato, Galizia, Gennaro, De Vita, Ferdinando
Publicado em 2007

Overcoming resistance to molecularly targeted anticancer therapies: rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies

Por Tortora, Giampaolo, Bianco, Roberto, Daniele, Gennaro, Ciardiello, Fortunato, McCubrey, James A, Ricciardi, Maria Rosaria, Ciuffreda, Ludovica, Cognetti, Francesco, Tafuri, Agostino, Milella, Michele
Publicado em 2007

KRAS Mutations Testing in Colorectal Carcinoma Patients in Italy: From Guidelines to External Quality Assessment

Por Normanno, Nicola, Pinto, Carmine, Castiglione, Francesca, Bardelli, Alberto, Gambacorta, Marcello, Botti, Gerardo, Nappi, Oscar, Siena, Salvatore, Ciardiello, Fortunato, Taddei, GianLuigi, Marchetti, Antonio
Publicado em 2011

Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and Patient...

Por Ciardiello, Fortunato, Adams, Richard, Tabernero, Josep, Seufferlein, Thomas, Taieb, Julien, Moiseyenko, Vladimir, Ma, Brigette, Lopez, Gustavo, Vansteenkiste, Johan F., Esser, Regina, Tejpar, Sabine
Publicado no Oncologist (2016)